Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin - Takeaway - MDSpire
Conference News

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. According to the American Cancer Society, in 2025, about 154,270 individ...

Share

  • 1

    Colorectal cancer ranks third in diagnosis rates in the U.S.

  • 2

    154,270 new cases expected in

  • 3

    GLP-1RAs could reduce cancer risk by 36% compared to aspirin.

  • 4

    Aspirin has serious side effects limiting its use for prevention.

  • 5

    Study involved 281,656 participants matched on demographics.

  • 6

    Findings suggest GLP-1RAs may enhance public health strategies for cancer prevention.

  • 7

    Future research needed to validate these results.

Original Source(s)

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

  • by Jo Cavallo

  • April 3, 2026

Related Content

FDA Grants Traditional Approval to Brexucabtagene Autoleucel for Relapsed or Refractory MCL

The CAR T-cell therapy brexucabtagene autoleucel (Tecartus) was issued full approval for adult patients with relapsed or refractory mantle cell lymphoma (MCL). The approval now includes efficacy, safe...

HER2CLIMB-05 Study: Tucatinib Enhances Progression-Free Survival as First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

The addition of the selective HER2 inhibitor tucatinib to trastuzumab and pertuzumab as first-line maintenance therapy significantly prolonged investigator-assessed progression-free survival in patien...

Turning Proteins into DNA for Ultra-Sensitive Sequencing

Stanford researchers repurpose DNA sequencing technology to read proteins at single-molecule resolution, complementing – and potentially surpassing – mass spectrometry

  • April 2, 2026

  • 2 min